In Vivo Analysis of Implant-Associated Bacterial Infections Using Zebrafish Embryos
JoVE Encyclopedia of Experiments
Microbiology
0 views • 3:12 min • September 26th, 2025
Begin with a dish containing an agarose chamber molded with grooves.
Each groove holds anesthetized zebrafish embryos submerged in an embryo medium supplemented with an anesthetic agent.
Under a light microscope, insert a microinjection needle into the muscle tissue.
Inject a suspension containing S. aureus and polystyrene microspheres to model an implant-associated infection.
Transfer the injected embryos into individual wells of a multi-well plate filled with a fresh medium and incubate.
Microspheres offer a physical surface that supports bacterial colonization and promotes infection.
To assess implant-associated bacterial infection, transfer each embryo into a separate tube and wash it with a buffer. Add buffer and ceramic beads.
Homogenize to lyse the embryos and release internal contents, including bacteria.
Plate the diluted homogenates, then incubate to allow colony formation.
Embryos injected with the microsphere–bacterial suspension show higher colony counts than those injected with the bacterial suspension alone. This indicates that the microspheres increase infection susceptibility.
After waiting five minutes for the embryos to be anesthetized, align the embryos within the grooves in a single orientation for their injection. Set the microinjector to the appropriate injection settings, and insert the needle into the muscle tissue of the first embryo at a 45 to 60-degree angle under a stereo microscope.
Gently move the needle back and forth to adjust the position within the tissue as necessary, and use the microinjector foot pedal to inject the loaded suspension. When injecting a bacteria microsphere suspension into the tissue of zebrafish embryos, the needle should be inserted gently but with a steady hand. After a successful insertion, a space should be created for the materials before injection.
And maintain the embryos in E3 medium without tricaine in individual wells of 48-well plates with daily medium changes. To monitor the infection progression by colony-forming unit quantification, randomly transfer five to six viable infected embryos into individual two-milliliter microtubes shortly after injection, and gently wash the embryos with sterile PBS. After discarding the washes, add 100 microliters of sterile PBS to each tube, followed by two to three sterile two-millimeter-diameter zirconia beads.
Then crush the embryos in a homogenizer at 3,500 rpm for 30 seconds, and culture the homogenate as demonstrated.
Overview
This study demonstrates a method for modeling implant-associated infections in zebrafish embryos using S. aureus and polystyrene microspheres. The approach allows for the assessment of bacterial colonization and infection susceptibility.
Key Study Components
Area of Science
- Microbiology
- Infection Models
- Zebrafish Research
Background
- Zebrafish embryos are used as a model organism for studying infections.
- Polystyrene microspheres can enhance bacterial colonization.
- Understanding implant-associated infections is crucial for biomedical applications.
- Infection progression can be monitored through colony-forming unit quantification.
Purpose of Study
- To evaluate the impact of microspheres on bacterial infection in zebrafish embryos.
- To establish a reliable method for studying implant-associated infections.
- To quantify bacterial colonization in a controlled environment.
Methods Used
- Anesthetized zebrafish embryos are injected with a bacterial suspension.
- Microspheres are used to model the infection environment.
- Embryos are incubated and monitored for infection progression.
- Colony counts are determined from homogenized embryo samples.
Main Results
- Embryos injected with microsphere-bacterial suspensions showed higher colony counts.
- Microspheres significantly increased infection susceptibility.
- The method allows for precise monitoring of infection dynamics.
- Results support the use of zebrafish as a model for studying infections.
Conclusions
- Microspheres enhance bacterial colonization in zebrafish embryos.
- This model can be used for further studies on implant-associated infections.
- The findings contribute to understanding infection mechanisms in biomedical contexts.
Frequently Asked Questions
Executive Industry Relevance
This zebrafish embryo model enables early-stage assessment of biomaterial-associated infection risk, supporting target validation in anti-infective development. By quantifying bacterial colonization in a living system, it provides mechanistic insights that de-risk preclinical candidates. The approach aligns with discovery-stage needs for predictive, reproducible infection models.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by testing how implanted materials influence bacterial survival and infection susceptibility.
- Operational Value: Enables functional target validation through quantifiable colony-forming unit readouts in a disease-relevant system.
- Predictive Value: Supports portfolio triage by identifying compounds or coatings that reduce infection-promoting effects of biomaterials.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for antimicrobial compound screening using standardized infection readouts.
- Operational Value: Delivers reproducible, quantitative outputs (CFU counts) that enable assay scalability and cross-lab consistency.
- Strategic Value: Enhances screening readiness by providing a dynamic, in vivo context for evaluating anti-infective efficacy.
Translational & Preclinical Research
- Scientific Value: Maintains disease relevance by modeling implant-associated Staphylococcus aureus infection in a vertebrate host.
- Operational Value: Ensures translational continuity from discovery through preclinical validation via consistent infection quantification.
- Risk Mitigation: Supports risk-adjusted advancement decisions by revealing infection-promoting properties of candidate biomaterials early.
Pipeline & Workflow Integration
The model fits within the discovery continuum, informing lead identification and preclinical work by providing infection susceptibility data linked to biomaterial properties.
- Discovery Biology: Supports hypothesis testing on how implant surfaces modulate bacterial colonization and host-pathogen interactions.
- Screening: Delivers assay-ready, reproducible infection models with quantifiable bacterial load outputs for compound evaluation.
- Analytics: Generates colony-forming unit measurements that enable statistical comparison of infection conditions across experimental groups.
- Translational Research: Connects early infection mechanisms to preclinical continuity through vertebrate-model validation of biomaterial risks.
- Enterprise Reuse: Functions as a reusable platform for assessing infection risk across multiple biomaterial and antimicrobial candidates.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity in implant-associated infection pathways.
- Operational Value: Standardizes infection modeling through reproducible embryo preparation, injection, and quantification workflows.
- Strategic Value: Improves go/no-go decisions by identifying infection-enhancing biomaterials before costly preclinical investment.
- Portfolio Impact: Enables risk-adjusted prioritization of biomaterials based on quantified infection susceptibility in a living system.
Implementation Considerations
- Requires expertise in zebrafish embryo handling, microinjection techniques, and anaerobic bacterial work.
- Dependent on stereomicroscopy, microinjectors, homogenizers, and CFU plating infrastructure.
- Necessitates cross-team standardization of embryo staging, injection volume, and incubation timing for data comparability.
- Involves adaptation considerations when modeling different bacterial species or biomaterial types beyond polystyrene microspheres.
- Practical limitations include embryo viability constraints post-infection and the need for sterile workflows to avoid confounding contamination.
Biopharma FAQs
Microstructured Devices for Optimized Microinjection and Imaging of Zebrafish Larvae
Related Videos
0 Views
Antimicrobial Characterization of Advanced Materials for Bioengineering Applications
Related Videos
0 Views
Oral Biofilm Formation on Different Materials for Dental Implants
Related Videos
0 Views
Infection of Zebrafish Embryos with Intracellular Bacterial Pathogens
Related Videos
0 Views
Non-invasive Imaging of Disseminated Candidiasis in Zebrafish Larvae
Related Videos
0 Views
zPDX-Analysis of Invasiveness: Investigating Invasive Behavior of Metastatic Cancer Cells in Zebrafish Embryo Xenografts
Related Videos
0 Views
Fluorescence Imaging of Biomaterial-Associated Bacterial Infection in Zebrafish Embryos
Related Videos
0 Views
Isolation and Cultivation of Bacteria from Zebrafish Embryos to Assess Infection Load
Related Videos
0 Views
Establishment and Optimization of a High Throughput Setup to Study Staphylococcus epidermidis and Mycobacterium marinum Infection as a Model for Drug Discovery
Related Videos
0 Views
Non-invasive Imaging of the Innate Immune Response in a Zebrafish Larval Model of Streptococcus iniae Infection
Related Videos
0 Views
Last updated: 29 August 2026